Jared Whitlock

Reporter

Email: jwhitlock@sdbj.com
Phone: 858-634-4636 Extension: 3130

Recent Stories

Odonate Therapeutics Files for $173 M IPO

San Diego-based Odonate Therapeutics has filed with the SEC to raise up to $173 million in an IPO.

Ionis Confident It Can Compete With Alnylam

PHARMA: Cos. Clash as They Target Same Illness

Tax Reform May Threaten Incentives for Orphan Drug Research

PHARMA: Sector Lobbies Against Changes; Cut Said to Bring $54B Over 10 Years

Drugmakers researching medicines for rare diseases could lose all or part of a tax credit under Republican tax overhaul proposals unveiled this month, sparking concern among San Diego’s biotech industry.

Tease photo

Arcturus Completes Merger with Alcobra, Lists on Nasdaq

San Diego’s Arcturus Therapeutics is now on the public markets following a merger with Alcobra, previously based in Israel.

Palomar Health to Build New Crisis Stabilization Unit

A standalone crisis stabilization unit will be built on the Palomar Medical Center Escondido campus.

UC San Diego Forms Medical Records Partnership

UC San Diego and UC Irvine Health are now on an integrated electronic medical records platform.

Heron Wins FDA Approval for Chemotherapy Drug

The FDA has approved Heron Therapeutic's Cinvanti, an injectable drug for the prevention of chemotherapy-induced nausea and vomiting.

MaxLinear Reports Record Q3 Revenue

Carlsbad chipmaker MaxLinear Inc. reported a net loss of $9.2 million on record quarterly revenue of $113.6 million.

Heron Therapeutics Wins FDA Approval for Chemotherapy Drug

The FDA has approved Heron Therapeutic's Cinvanti, an injectable drug for the prevention of chemotherapy-induced nausea and vomiting.

Palomar Health CEO Retires

Robert Hemker has announced his retirement as president and CEO of Palomar Health.

More stories >>